ALK gene alterations in cancer: biological aspects and therapeutic implications
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 23, 2017 Category: Genetics & Stem Cells Authors: Raffaele Palmirotta Davide Quaresmini Domenica Lovero Franco Silvestris Source Type: research

Pharmacogenomics testing in a community pharmacy: patient perceptions and willingness-to-pay
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 23, 2017 Category: Genetics & Stem Cells Authors: Mara L Gibson Kenneth C Hohmeier Cindy T Smith Source Type: research

Association of Fcgamma receptor type 2A and 3A genotypes with rheumatoid arthritis in Chinese population
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 23, 2017 Category: Genetics & Stem Cells Authors: Yining Sun Lingfei Mo Xiuyuan Feng Dongmei Yang Taochao Tan Lingxia Zeng Lingyun Hui Yawen Wang Cheng Liu Lan He Source Type: research

Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 23, 2017 Category: Genetics & Stem Cells Authors: Qian-Qian Song Wan-Ying Xie Yong-Jun Tang Jun Zhang Jie Liu Source Type: research

ATP-binding casette transporter expression in acute myeloid leukemia: association with in vitro cytotoxicity and prognostic markers
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 23, 2017 Category: Genetics & Stem Cells Authors: Savitha Varatharajan Ajay Abraham Sreeja Karathedath Sukanya Ganesan Kavitha M Lakshmi Nancy Arthur Vivi M Srivastava Biju George Alok Srivastava Vikram Mathews Poonkuzhali Balasubramanian Source Type: research

A nationwide survey of pharmacists ’ perception of pharmacogenetics in the context of a clinical decision support system containing pharmacogenetics dosing recommendations
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 23, 2017 Category: Genetics & Stem Cells Authors: Paul CD Bank Jesse J Swen Henk-Jan Guchelaar Source Type: research

Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 13, 2017 Category: Genetics & Stem Cells Authors: P är Hallberg Matilda Persson Tomas Axelsson Marco Cavalli Pia Norling Hans-Erik Johansson Qun-Ying Yue Patrik KE Magnusson Claes Wadelius Niclas Eriksson Mia Wadelius Source Type: research

Donors FMO3 polymorphisms affect tacrolimus elimination in Chinese liver transplant patients
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 13, 2017 Category: Genetics & Stem Cells Authors: Lei Ren Mujian Teng Tao Zhang Xiaoqing Zhang Bo Sun Shengying Qin Lin Zhong Zhihai Peng Junwei Fan Source Type: research

Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 13, 2017 Category: Genetics & Stem Cells Authors: P är Hallberg Matilda Persson Tomas Axelsson Marco Cavalli Pia Norling Hans-Erik Johansson Qun-Ying Yue Patrik KE Magnusson Claes Wadelius Niclas Eriksson Mia Wadelius Source Type: research

Donors FMO3 polymorphisms affect tacrolimus elimination in Chinese liver transplant patients
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - January 13, 2017 Category: Genetics & Stem Cells Authors: Lei Ren Mujian Teng Tao Zhang Xiaoqing Zhang Bo Sun Shengying Qin Lin Zhong Zhihai Peng Junwei Fan Source Type: research

Correlations between the enantio- and regio-selective metabolisms of warfarin
Pharmacogenomics January 2017, Vol. 18, No. 2, Pages 133-142. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 20, 2016 Category: Genetics & Stem Cells Authors: Harumi Takahashi Minami Ohara Soichi Shibata Ming Ta Michael Lee Larisa H Cavallari Edith A Nutescu Maria G Scordo Vittorio Pengo Roberto Padrini Koichiro Atsuda Hajime Matsubara Yuan Tsong Chen Hirotoshi Echizen Source Type: research

Correlations between the enantio- and regio-selective metabolisms of warfarin
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 20, 2016 Category: Genetics & Stem Cells Authors: Harumi Takahashi Minami Ohara Soichi Shibata Ming Ta Michael Lee Larisa H Cavallari Edith A Nutescu Maria G Scordo Vittorio Pengo Roberto Padrini Koichiro Atsuda Hajime Matsubara Yuan Tsong Chen Hirotoshi Echizen Source Type: research

Trough concentration and ABCG2 polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysis
Pharmacogenomics January 2017, Vol. 18, No. 1, Pages 35-56. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 19, 2016 Category: Genetics & Stem Cells Authors: Zhi-Ping Jiang Xie-Lan Zhao Naoto Takahashi Sabrina Angelini Biswajit Dubashi Li Sun Ping Xu Source Type: research

Are gene polymorphisms related to treatment outcomes of methotrexate in patients with rheumatoid arthritis? A systematic review and meta-analysis
Pharmacogenomics January 2017, Vol. 18, No. 2, Pages 175-195. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 19, 2016 Category: Genetics & Stem Cells Authors: Yuehong Chen Kun Zou Jianhong Sun Yuan Yang Gang Liu Source Type: research

Fine-mapping of antipsychotic response genome-wide association studies reveals novel regulatory mechanisms
Pharmacogenomics January 2017, Vol. 18, No. 2, Pages 105-120. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 19, 2016 Category: Genetics & Stem Cells Authors: Ellen S Ovenden Britt I Dr ögemöller Lize van der Merwe Bonginkosi Chiliza Laila Asmal Robin A Emsley Louise Warnich Source Type: research

What is the future of pharmacogenomics in pain management?
Pharmacogenomics January 2017, Vol. 18, No. 2, Pages 101-103. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 19, 2016 Category: Genetics & Stem Cells Authors: Ana M Peir ó C ésar Margarit Adri án LLerena Source Type: research

What is the future of pharmacogenomics in pain management?
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 19, 2016 Category: Genetics & Stem Cells Authors: Ana M Peir ó C ésar Margarit Adri án LLerena Source Type: research

Are gene polymorphisms related to treatment outcomes of methotrexate in patients with rheumatoid arthritis? A systematic review and meta-analysis
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 19, 2016 Category: Genetics & Stem Cells Authors: Yuehong Chen Kun Zou Jianhong Sun Yuan Yang Gang Liu Source Type: research

Fine-mapping of antipsychotic response genome-wide association studies reveals novel regulatory mechanisms
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 19, 2016 Category: Genetics & Stem Cells Authors: Ellen S Ovenden Britt I Dr ögemöller Lize van der Merwe Bonginkosi Chiliza Laila Asmal Robin A Emsley Louise Warnich Source Type: research

Trough concentration and ABCG2 polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysis
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 19, 2016 Category: Genetics & Stem Cells Authors: Zhi-Ping Jiang Xie-Lan Zhao Naoto Takahashi Sabrina Angelini Biswajit Dubashi Li Sun Ping Xu Source Type: research

Pharmacogenetic considerations in the treatment of HIV
Pharmacogenomics January 2017, Vol. 18, No. 1, Pages 85-98. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 15, 2016 Category: Genetics & Stem Cells Authors: Vanessa S Mattevi Carmela FS Tagliari Source Type: research

Clinical impact of the CYP3A5 6986A > G allelic variant on kidney transplantation outcomes
Pharmacogenomics January 2017, Vol. 18, No. 2, Pages 165-173. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 15, 2016 Category: Genetics & Stem Cells Authors: Adrien Flahault Dany Anglicheau Marie-Anne Loriot Eric Thervet Nicolas Pallet Source Type: research

Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis
Pharmacogenomics January 2017, Vol. 18, No. 2, Pages 157-164. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 15, 2016 Category: Genetics & Stem Cells Authors: Roc ío Prieto-Pérez Mar Llamas-Velasco Teresa Cabaleiro Guillermo Solano-L ópez Beatriz M árquez Manuel Rom án Dolores Ochoa Mar ía Talegón Esteban Daud én Francisco Abad-Santos Source Type: research

Fatty acid amide hydrolase –morphine interaction influences ventilatory response to hypercapnia and postoperative opioid outcomes in children
Pharmacogenomics January 2017, Vol. 18, No. 2, Pages 143-156. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 15, 2016 Category: Genetics & Stem Cells Authors: Vidya Chidambaran Valentina Pilipenko Kristie Spruance Raja Venkatasubramanian Jing Niu Tsuyoshi Fukuda Tomoyuki Mizuno Kejian Zhang Kenneth Kaufman Alexander A Vinks Lisa J Martin Senthilkumar Sadhasivam Source Type: research

Prediction of atorvastatin plasmatic concentrations in healthy volunteers using integrated pharmacogenetics sequencing
Pharmacogenomics January 2017, Vol. 18, No. 2, Pages 121-131. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 15, 2016 Category: Genetics & Stem Cells Authors: Omar Fernando Cruz-Correa Rafael Baltazar Reyes Le ón-Cachón Hugo Alberto Barrera-Salda ña Xavier Sober ón Source Type: research

Fatty acid amide hydrolase –morphine interaction influences ventilatory response to hypercapnia and postoperative opioid outcomes in children
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 15, 2016 Category: Genetics & Stem Cells Authors: Vidya Chidambaran Valentina Pilipenko Kristie Spruance Raja Venkatasubramanian Jing Niu Tsuyoshi Fukuda Tomoyuki Mizuno Kejian Zhang Kenneth Kaufman Alexander A Vinks Lisa J Martin Senthilkumar Sadhasivam Source Type: research

Clinical impact of the CYP3A5 6986A > G allelic variant on kidney transplantation outcomes
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 15, 2016 Category: Genetics & Stem Cells Authors: Adrien Flahault Dany Anglicheau Marie-Anne Loriot Eric Thervet Nicolas Pallet Source Type: research

Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 15, 2016 Category: Genetics & Stem Cells Authors: Roc ío Prieto-Pérez Mar Llamas-Velasco Teresa Cabaleiro Guillermo Solano-L ópez Beatriz M árquez Manuel Rom án Dolores Ochoa Mar ía Talegón Esteban Daud én Francisco Abad-Santos Source Type: research

Pharmacogenetic considerations in the treatment of HIV
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 15, 2016 Category: Genetics & Stem Cells Authors: Vanessa S Mattevi Carmela FS Tagliari Source Type: research

Prediction of atorvastatin plasmatic concentrations in healthy volunteers using integrated pharmacogenetics sequencing
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 15, 2016 Category: Genetics & Stem Cells Authors: Omar Fernando Cruz-Correa Rafael Baltazar Reyes Le ón-Cachón Hugo Alberto Barrera-Salda ña Xavier Sober ón Source Type: research

Allogeneic hematopoietic stem cell transplantation improves the prognosis of p16-deleted adult patients with acute lymphoblastic leukemia
Pharmacogenomics January 2017, Vol. 18, No. 1, Pages 77-84. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 14, 2016 Category: Genetics & Stem Cells Authors: Yan Wang Guoshu Chen Rui Cao Jie Li Lingli He Xutao Guo Jiabao Liang Pengcheng Shi Yong Zhou Bing Xu Source Type: research

Effect of polymorphisms in CYP3A4, PPARA, NR1I2, NFKB1, ABCG2 and SLCO1B1 on the pharmacokinetics of lovastatin in healthy Chinese volunteers
Pharmacogenomics January 2017, Vol. 18, No. 1, Pages 65-75. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 14, 2016 Category: Genetics & Stem Cells Authors: Guilian Zhao Mei Liu Xiujun Wu Guofei Li Feng Qiu Jingkai Gu Limei Zhao Source Type: research

Suppression of miR-628-3p and miR-641 is involved in rifampin-mediated CYP3A4 induction in HepaRG cells
Pharmacogenomics January 2017, Vol. 18, No. 1, Pages 57-64. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 14, 2016 Category: Genetics & Stem Cells Authors: Liang Yan Jingyang Liu Yunlong Zhao Yali Nie Xiaochao Ma Quancheng Kan Lirong Zhang Source Type: research

A novel acenocoumarol pharmacogenomic dosing algorithm for the Greek population of EU-PACT trial
Pharmacogenomics January 2017, Vol. 18, No. 1, Pages 23-34. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 14, 2016 Category: Genetics & Stem Cells Authors: Georgia Ragia Vana Kolovou Genovefa Kolovou Stavros Konstantinides Efstratios Maltezos Anna Tavridou Dimitrios Tziakas Anke H Maitland-van der Zee Vangelis G Manolopoulos Source Type: research

Association of polymorphisms in GAD1 and GAD2 genes with methamphetamine dependence
Pharmacogenomics January 2017, Vol. 18, No. 1, Pages 17-22. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 14, 2016 Category: Genetics & Stem Cells Authors: Siriluk Veerasakul Paritat Watiktinkorn Samur Thanoi Gavin P Reynolds Sutisa Nudmamud-Thanoi Source Type: research

The impact of the UGT1A1*60 allele on bilirubin serum concentrations
Pharmacogenomics January 2017, Vol. 18, No. 1, Pages 5-16. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 14, 2016 Category: Genetics & Stem Cells Authors: Amy L Pasternak Kristine R Crews Kelly E Caudle Colton Smith Deqing Pei Cheng Cheng Ulrich Broeckel Aditya H Gaur Jane Hankins Mary V Relling Cyrine E Haidar Source Type: research

What do we need to make genetic biomarker-guided treatment for renal cell carcinoma a reality?
Pharmacogenomics January 2017, Vol. 18, No. 1, Pages 1-4. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 14, 2016 Category: Genetics & Stem Cells Authors: Meta H Diekstra Xiaoyan Liu Jesse J Swen Henk-Jan Guchelaar Source Type: research

Effect of polymorphisms in CYP3A4, PPARA, NR1I2, NFKB1, ABCG2 and SLCO1B1 on the pharmacokinetics of lovastatin in healthy Chinese volunteers
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 14, 2016 Category: Genetics & Stem Cells Authors: Guilian Zhao Mei Liu Xiujun Wu Guofei Li Feng Qiu Jingkai Gu Limei Zhao Source Type: research

What do we need to make genetic biomarker-guided treatment for renal cell carcinoma a reality?
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 14, 2016 Category: Genetics & Stem Cells Authors: Meta H Diekstra Xiaoyan Liu Jesse J Swen Henk-Jan Guchelaar Source Type: research

The impact of the UGT1A1*60 allele on bilirubin serum concentrations
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 14, 2016 Category: Genetics & Stem Cells Authors: Amy L Pasternak Kristine R Crews Kelly E Caudle Colton Smith Deqing Pei Cheng Cheng Ulrich Broeckel Aditya H Gaur Jane Hankins Mary V Relling Cyrine E Haidar Source Type: research

A novel acenocoumarol pharmacogenomic dosing algorithm for the Greek population of EU-PACT trial
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 14, 2016 Category: Genetics & Stem Cells Authors: Georgia Ragia Vana Kolovou Genovefa Kolovou Stavros Konstantinides Efstratios Maltezos Anna Tavridou Dimitrios Tziakas Anke H Maitland-van der Zee Vangelis G Manolopoulos Source Type: research

Association of polymorphisms in GAD1 and GAD2 genes with methamphetamine dependence
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 14, 2016 Category: Genetics & Stem Cells Authors: Siriluk Veerasakul Paritat Watiktinkorn Samur Thanoi Gavin P Reynolds Sutisa Nudmamud-Thanoi Source Type: research

Suppression of miR-628-3p and miR-641 is involved in rifampin-mediated CYP3A4 induction in HepaRG cells
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 14, 2016 Category: Genetics & Stem Cells Authors: Liang Yan Jingyang Liu Yunlong Zhao Yali Nie Xiaochao Ma Quancheng Kan Lirong Zhang Source Type: research

Allogeneic hematopoietic stem cell transplantation improves the prognosis of p16-deleted adult patients with acute lymphoblastic leukemia
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 14, 2016 Category: Genetics & Stem Cells Authors: Yan Wang Guoshu Chen Rui Cao Jie Li Lingli He Xutao Guo Jiabao Liang Pengcheng Shi Yong Zhou Bing Xu Source Type: research

Pathophysiology of aortic aneurysm: insights from human genetics and mouse models
Pharmacogenomics December 2016, Vol. 17, No. 18, Pages 2071-2080. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 6, 2016 Category: Genetics & Stem Cells Authors: Nicole K Wilson Russell A Gould Elena Gallo MacFarlane MIBAVA Leducq Consortium Source Type: research

Pathophysiology of aortic aneurysm: insights from human genetics and mouse models
Pharmacogenomics Ahead of Print. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 6, 2016 Category: Genetics & Stem Cells Authors: Nicole K Wilson Russell A Gould Elena Gallo MacFarlane MIBAVA Leducq Consortium Source Type: research

The neuroimmune transcriptome and alcohol dependence: potential for targeted therapies
Pharmacogenomics December 2016, Vol. 17, No. 18, Pages 2081-2096. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 5, 2016 Category: Genetics & Stem Cells Authors: Anna Warden Emma Erickson Gizelle Robinson R Adron Harris R Dayne Mayfield Source Type: research

ABCB1 genotyping in the treatment of depression
Pharmacogenomics December 2016, Vol. 17, No. 18, Pages 2039-2069. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 5, 2016 Category: Genetics & Stem Cells Authors: Tanja Maria Br ückl Manfred Uhr Source Type: research

Genome-wide miRNAs expression profiles of Schistosoma japonicum schistosomula in response to artesunate
Pharmacogenomics December 2016, Vol. 17, No. 18, Pages 2025-2037. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 5, 2016 Category: Genetics & Stem Cells Authors: Qing-Ming Kong Xiao Zhu Qun-Bo Tong Bin Zheng Na-Yu Shi Di Lou Jian-Zu Ding Jian-Ping Jia Xiao-Heng Chen Rui Chen Shao-Hong Lu Source Type: research

Polymorphisms of ABAT, SCN2A and ALDH5A1 may affect valproic acid responses in the treatment of epilepsy in Chinese
Pharmacogenomics December 2016, Vol. 17, No. 18, Pages 2007-2014. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - December 5, 2016 Category: Genetics & Stem Cells Authors: Xi Li Jun Zhang Xi Wu Han Yan Yin Zhang Ruo-Hui He Yong-Jun Tang Yi-Jing He Dan Tan Xiao-Yuan Mao Ji-Ye Yin Zhao-Qian Liu Hong-Hao Zhou Jie Liu Source Type: research